Stock Scorecard
Stock Summary for CASI Pharmaceuticals Inc (CASI) - $2.34 as of 5/2/2024 6:41:09 PM EST
Total Score
8 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CASI
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CASI
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CASI
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for CASI
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for CASI
Financial Details for CASI
Company Overview |
|
|---|---|
| Ticker | CASI |
| Company Name | CASI Pharmaceuticals Inc |
| Country | China |
| Description | CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and markets therapeutic and pharmaceutical products in China, the United States, and internationally. The company is headquartered in Rockville, Maryland. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 2.34 |
| Last Day Price Updated | 5/2/2024 6:41:09 PM EST |
| Last Day Volume | 5,733 |
| Average Daily Volume | 45,087 |
| 52-Week High | 8.48 |
| 52-Week Low | 1.85 |
| Last Price to 52 Week Low | 26.49% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 67.80 |
| Sector PE | 54.24 |
| 5-Year Average PE | -2.83 |
| Free Cash Flow Ratio | 1.84 |
| Industry Free Cash Flow Ratio | 13.66 |
| Sector Free Cash Flow Ratio | 31.75 |
| Current Ratio Most Recent Quarter | 3.55 |
| Total Cash Per Share | 1.27 |
| Book Value Per Share Most Recent Quarter | 1.81 |
| Price to Book Ratio | 1.44 |
| Industry Price to Book Ratio | 5.72 |
| Sector Price to Book Ratio | 22.23 |
| Price to Sales Ratio Twelve Trailing Months | 1.03 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.44 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.15 |
Share Statistics |
|
| Total Shares Outstanding | 13,401,400 |
| Market Capitalization | 31,359,276 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 31.65% |
| Reported EPS 12 Trailing Months | -2.02 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | -2.02 |
| Net Income Twelve Trailing Months | -26,344,000 |
| Net Income Past Year | -26,938,000 |
| Net Income Prior Year | -39,411,000 |
| Quarterly Revenue Growth YOY | -55.00% |
| 5-Year Revenue Growth | 0.00% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 17,083,000 |
| Total Cash Past Year | 17,083,000 |
| Total Cash Prior Year | 47,112,000 |
| Net Cash Position Most Recent Quarter | -1,812,000 |
| Net Cash Position Past Year | -1,812,000 |
| Long Term Debt Past Year | 18,895,000 |
| Long Term Debt Prior Year | 466,000 |
| Total Debt Most Recent Quarter | 18,895,000 |
| Equity to Debt Ratio Past Year | 0.56 |
| Equity to Debt Ratio Most Recent Quarter | 0.56 |
| Total Stockholder Equity Past Year | 24,165,000 |
| Total Stockholder Equity Prior Year | 44,574,000 |
| Total Stockholder Equity Most Recent Quarter | 24,165,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.40 |
| MACD Signal | -0.46 |
| 20-Day Bollinger Lower Band | 1.37 |
| 20-Day Bollinger Middle Band | 4.75 |
| 20-Day Bollinger Upper Band | 8.13 |
| Beta | 0.33 |
| RSI | 33.42 |
| 50-Day SMA | 3.77 |
| 200-Day SMA | 9.54 |
System |
|
| Modified | 5/1/2024 8:18:28 PM EST |